Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Snoeck

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Breast Cancer Research and Treatment|January 1, 1994
Vorozole, a specific non-steroidal aromatase inhibitorW Wouters, E Snoeck, R De Coster
Physical Review Letters|March 5, 2009
Unexpected resonant response in [Fe(001)/Cr(001)]10/MgO(001) multilayers in a magnetic fieldF G Aliev, V V Pryadun, E Snoeck
Drug Discovery Today|July 27, 2001
Modelling and simulation in clinical drug developmentK F. Rooney, E Snoeck, P H. Watson
Psychopharmacology|May 1, 1994
Plasma protein binding of risperidone and its distribution in bloodG Mannens, W Meuldermans, E Snoeck, et al.
Ultramicroscopy|January 31, 2017
Optimising electron microscopy experiment through electron optics simulationY Kubo, C Gatel, E Snoeck, et al.
Journal of Pharmacokinetics and Biopharmaceutics|March 23, 2000
A combined specific target site binding and pharmacokinetic model to explore the non-linear disposition of draflazineE Snoeck, P Jacqmin, A Van Peer, et al.
Ultramicroscopy|August 26, 2011
Dark-field electron holography for the measurement of geometric phaseM J Hÿtch, F Houdellier, F Hüe, et al.
European Journal of Clinical Pharmacology|January 1, 1996
Haemodynamic effects and pharmacokinetics of oral d- and l-nebivolol in hypertensive patientsA Himmelmann, T Hedner, E Snoeck, et al.
European Journal of Drug Metabolism and Pharmacokinetics|January 1, 1993
Pharmacokinetic-pharmacodynamic relationships in phase I/phase II of drug developmentA Van Peer, E Snoeck, M L Huang, et al.
Physical Review Letters|July 30, 2013
Counting elementary charges on nanoparticles by electron holographyC Gatel, A Lubk, G Pozzi, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Breast Cancer Research and Treatment|January 1, 1994
Vorozole, a specific non-steroidal aromatase inhibitorW Wouters, E Snoeck, R De Coster
Physical Review Letters|March 5, 2009
Unexpected resonant response in [Fe(001)/Cr(001)]10/MgO(001) multilayers in a magnetic fieldF G Aliev, V V Pryadun, E Snoeck
Drug Discovery Today|July 27, 2001
Modelling and simulation in clinical drug developmentK F. Rooney, E Snoeck, P H. Watson
Psychopharmacology|May 1, 1994
Plasma protein binding of risperidone and its distribution in bloodG Mannens, W Meuldermans, E Snoeck, et al.
Ultramicroscopy|January 31, 2017
Optimising electron microscopy experiment through electron optics simulationY Kubo, C Gatel, E Snoeck, et al.
Journal of Pharmacokinetics and Biopharmaceutics|March 23, 2000
A combined specific target site binding and pharmacokinetic model to explore the non-linear disposition of draflazineE Snoeck, P Jacqmin, A Van Peer, et al.
Ultramicroscopy|August 26, 2011
Dark-field electron holography for the measurement of geometric phaseM J Hÿtch, F Houdellier, F Hüe, et al.
European Journal of Clinical Pharmacology|January 1, 1996
Haemodynamic effects and pharmacokinetics of oral d- and l-nebivolol in hypertensive patientsA Himmelmann, T Hedner, E Snoeck, et al.
European Journal of Drug Metabolism and Pharmacokinetics|January 1, 1993
Pharmacokinetic-pharmacodynamic relationships in phase I/phase II of drug developmentA Van Peer, E Snoeck, M L Huang, et al.
Physical Review Letters|July 30, 2013
Counting elementary charges on nanoparticles by electron holographyC Gatel, A Lubk, G Pozzi, et al.
Pageof 5